February 15, 2023 Airway Therapeutics Joins C-Path’s International Neonatal Consortium TUCSON, Ariz., February 15, 2023 — Critical Path Institute (C-Path) today announced that Airway Therapeutics, Inc. (“Airway”
Regulus Therapeutics Joins PKDOC C-Path is excited to announce that Regulus Therapeutics, Inc. has joined the Polycystic Kidney Disease Outcomes Consortium (PKD
April 18, 2023-April 20, 2023 April 18 – 20 | 2023 CDRC Annual Meeting C-Path’s Cure Drug Repurposing Collaboratory will host an in-person, three-day annual Conference and Regulatory Workshop
April 9, 2023-April 10, 2023 14th Annual Patient-Reported Outcome Consortium Workshop April 19 – 20, 2023 DoubleTree by Hilton Silver Spring DC North 8777 Georgia Avenue Silver Spring, MD 20910 On April 19–20, 20
February 22, 2023 Breaking Down Barriers in Support of Patients with Rare Diseases You’re invited to join C-Path’s Gina Calarco Smith at the upcoming Breaking Down Barriers in Support of Ra
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Joins PKDOC C-Path is excited to announce that Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) has joined its Polycy
January 25, 2023 C-Path Receives Letter of Support from EMA on Duchenne Muscular Dystrophy Clinical Trial Simulation Platform TUCSON, Ariz., Jan. 25, 2023 — Critical Path Institute (C-Path) today announced that the European Medicines Agency (EMA) has iss
C-Path and Mobilise-D Collaborate to Improve Impact on the Organizations’ Common Goals Critical Path Institute is pleased to announce the recent collaboration agreement between C-Path and Mobilise-D. By
February 8, 2023 TRxA 2023 Funding Opportunities C-Path's Translational Therapeutics Accelerator is a global drug discovery support program...
Using Real World Data from CURE ID to Identify Drug Repurposing Opportunities in Mycology: Impact of Climate Change